Back to mobile site

Stifel Reiterates Buy Rating on Clearpoint Neuro Inc. (CLPT)

June 9, 2026 9:09 AM EDT Send to a Friend
Stifel analyst Tom Stephan reiterated a Buy rating and $16.00 price target on Clearpoint Neuro Inc. (NASDAQ: CLPT).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login